Home › AstraZeneca cancer drug, companion test approved
 

Keywords :   


AstraZeneca cancer drug, companion test approved

2014-12-19 21:03:21| Biotech - Topix.net

U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC . The drug is for women whose ovarian cancer is associated with certain defective genes and whose cancer persists after multiple treatments.

Tags: test approved drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Fujitsu sacked boss at height of Horizon scandal
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05Businessman Tony O'Reilly dies after short illness
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »